You can buy or sell Centogene and other stocks, options, and ETFs commission-free!
Centogene N.V. Common Shares, also called Centogene, is a commercial-stage company. It focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. It operates through the following two segments: Pharmaceutical and Clinical Diagnostics. The Pharmaceutical segment provides services to pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery and patient monitoring. The Clinical Diagnostics segment provides targeted genetic sequencing and diagnostics services. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark. The listed name for CNTG is Centogene N.V. Common Shares.
52 Week High
52 Week Low
— per share
Expected Apr 22, Pre-Market